Disease burden of hematological malignancies worldwide, in China and in the United States based on the GLOBOCAN 2022 and Global Burden of Disease 2021 data
Abstract. Background:. Hematological malignancies are a heterogeneous group of diseases caused by disruptions in normal hematopoietic function. This study aimed to evaluate the global burden of hematological malignancies, including Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), multiple myeloma...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer
2026-04-01
|
| Col·lecció: | Chinese Medical Journal |
| Accés en línia: | http://journals.lww.com/10.1097/CM9.0000000000003969 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|